Marubi(SH:603983) Xin Lang Cai Jing·2025-11-27 03:07Core Viewpoint - Marubi Biotechnology's stock has shown fluctuations in recent trading sessions, with a year-to-date increase of 8.63% and a recent decline over the past 60 days of 15.88% [1][2]. Company Overview - Marubi Biotechnology Co., Ltd. was established on April 2, 2002, and went public on July 25, 2019. The company is located in Guangzhou and specializes in the research, design, production, sales, and service of various skincare products [1]. - The revenue composition of Marubi includes skincare products (39.05%), beauty and other products (29.37%), eye care products (23.81%), cleansing products (7.67%), and other businesses (0.10%) [1]. Financial Performance - For the period from January to September 2025, Marubi achieved a revenue of 2.45 billion yuan, representing a year-on-year growth of 25.51%. The net profit attributable to the parent company was 244 million yuan, with a growth of 2.13% [2]. - Since its A-share listing, Marubi has distributed a total of 1.08 billion yuan in dividends, with 710 million yuan distributed over the past three years [3]. Shareholder Information - As of September 30, 2025, the number of shareholders for Marubi was 18,900, an increase of 8.86% from the previous period. The average number of circulating shares per person was 21,205, a decrease of 8.14% [2]. - Among the top ten circulating shareholders, several funds from the Fortune series hold significant stakes, with the largest being Fortune Consumption Theme Mixed A, holding 3.69 million shares [3].